Macrophage Efferocytosis as a Therapeutic Strategy in Intervertebral Disc Degeneration
Cell Proliferation · 2025-10 · 58 (10)
DOI: 10.1111/cpr.70068 ↗At a glance
Übersichtsarbeit in Cell Proliferation, published online on 2025-06-09. Written by Shijie Chen and 9 co-authors. Institution: Lanzhou University Second Hospital, Lanzhou, People's Republic of China. Major MEDLINE topics: Intervertebral Disc Degeneration, Macrophages, Phagocytosis. Cited 15 times so far (Crossref); 186 references. The full text is freely available (open access, CC BY 4.0). Funded by: Natural Science Foundation of Gansu Province, National Natural Science Foundation of China.
Abstract (original language)
In recent years, a growing number of studies have disclosed the substantial role of macrophages—key immune cells—in the pathological process of intervertebral disc degeneration. Researchers have categorised macrophage phenotypes into M1 and M2 polarisation, associating these polarisations with intervertebral disc degeneration. Essentially, macrophage phenotypes can be classified as either pro‐inflammatory or anti‐inflammatory. Induced by diverse factors, these distinct polarisation states exert contrary effects on disc injury and repair. Although numerous studies focus on the polarisation of macrophages and the cytokines they secrete in relation to intervertebral disc degeneration, these studies frequently neglect the relationship between the efferocytosis of macrophages and the progression of intervertebral disc degeneration. Efferocytosis is a specialised procedure in which phagocytes, such as macrophages, engulf and eliminate apoptotic cells. This process is crucial for maintaining tissue homeostasis and resolving inflammation. By effectively clearing these dying cells, efferocytosis helps prevent the release of potentially detrimental cellular contents, thereby facilitating healing and the resolution of inflammation. Simultaneously, macrophages digest the engulfed cell debris and release various cytokines that participate in tissue self‐repair. Therefore, this article presents an overview of the molecular mechanisms connecting macrophages and their efferocytosis activity to intervertebral disc degeneration, explores new directions for the utilisation of macrophages in the treatment of intervertebral disc degeneration, and discusses the future prospects for the development of therapeutic targets.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Lanzhou University Second Hospital, Lanzhou, People's Republic of China.
- Orthopaedics Key Laboratory of Gansu Province, Lanzhou, People's Republic of China.
- The Second People's Hospital of Gansu Province, Lanzhou, People's Republic of China.
ORCID profiles: Shijie Chen, Daxue Zhu, Yanhu Li, Yizhi Zhang, Huan Liu
Funding
- Natural Science Foundation of Gansu Province
- National Natural Science Foundation of China
Cite
APA
Chen, S., Zhang, H., Wang, Z., Zhu, D., Li, Y., Zhang, Y., Wang, D., Chen, S., Liu, H., & Kang, X. (2025). Macrophage Efferocytosis as a Therapeutic Strategy in Intervertebral Disc Degeneration. Cell Proliferation, 58(10). https://doi.org/10.1111/cpr.70068
Vancouver
Chen S, Zhang H, Wang Z, Zhu D, Li Y, Zhang Y, et al. Macrophage Efferocytosis as a Therapeutic Strategy in Intervertebral Disc Degeneration. Cell Proliferation. 2025;58(10). doi:10.1111/cpr.70068
BibTeX
@article{Chen2025,
author = {Chen, Shijie and Zhang, Haijun and Wang, Zhaoheng and Zhu, Daxue and Li, Yanhu and Zhang, Yizhi and Wang, Dongxin and Chen, Shuwei and Liu, Huan and Kang, Xuewen},
title = {Macrophage Efferocytosis as a Therapeutic Strategy in Intervertebral Disc Degeneration},
journal = {Cell Proliferation},
year = {2025},
volume = {58},
number = {10},
doi = {10.1111/cpr.70068}
}
EUVIMED